April 18, 2018
Comparison of disease modifying treatments in MS finds increased risk of infection in newer drugs
Over the past few years, Dr. Helen Tremlett and her team have been evaluating population...
Over the past few years, Dr. Helen Tremlett and her team have been evaluating population...
Heather Yong is a Directed Studies student in the Faculty of Medicine at the...
New research from Dr. Helen Tremlett’s Pharmacoepidemiology in Multiple Sclerosis Research Group suggests that...
People who live in areas where they are exposed to more of the sun’s...
A particular gene mutation associated with an inherited form of Parkinson’s disease (PD) offers...
Until now, researchers studying multiple sclerosis (MS) in mouse models have relied on models...
There are more than ten different drug therapies approved in Canada to treat multiple...
For people with multiple sclerosis (MS), the presence of comorbidities—chronic conditions in addition to...
Pictured: Dr. Eddie Pokrishevsky explains his work to MP Drouin (image credit: Geoff Lister)....
“I don’t pretend—and would never presume—to speak for all patients, or anyone but myself,”...
Diseases and injuries of the brain have a magnetic quality that can indicate the...
A Canadian clinical trial led by researchers at the University of Calgary’s Hotchkiss Brain...